Psoriatic Arthritis Treatment Market: Global Analysis Trends, Share, Size, Growth, Opportunity and Forecast 2021 - 2028
Psoriatic Arthritis Treatment Market |
Psoriatic arthritis is a kind of spondyloarthritis that is caused by an inflammatory joint condition caused by psoriasis. It affects the skin as well as the musculoskeletal system. Genetic and environmental variables have a role in its development. Psoriatic arthritis causes swollen toes, fingers, and painful joints, as well as lower back discomfort, pitted nails, and stiffness. Joint fluid testing, X-rays, rheumatoid factor (RF), and magnetic resonance imaging are used to diagnose psoriatic arthritis (MRI). NSAIDs, disease-modifying antirheumatic medications (DMARDs), biologics, and immunosuppressant medicines can all be used to treat psoriatic arthritis.
Rise in demand for psoriatic arthritis treatment products, surge in R&D activities to develop novel drugs for the treatment of psoriatic arthritis, surge in geriatric population, strong pipeline of biosimilar & biologic products, and rise in awareness toward psoriatic arthritis treatment are the major factors driving the growth of the global Psoriatic Arthritis Treatment Market. Other factors that contribute to the market's growth include an increase in the acceptance of psoriatic arthritis treatment medications, the presence of a large patient pool, the availability of patient support programmes, and an increase in healthcare spending.
Market Segmentation:
By Type
- Prescription
- OTC
By Route Of Administration
- Injectable
- Oral
- Topical
By Drug Type
- NSAIDs
- DMARDs
- Biologics
- Others
Psoriasis is one of the most common causes of psoriatic arthritis. As a result, one of the key reasons impacting the market positively is the rising incidence of psoriasis illness related to infection, stress, obesity, skin injuries, alcohol abuse, and vitamin deficiencies. Furthermore, because psoriatic arthritis is most frequent in people between the ages of 30 and 50, the global adult population is growing, adding to market expansion.
The major players operating in the global psoriatic arthritis market include AbbVie, Inc., Amgen, Inc., Johnson & Johnson Services, Inc., Bristol-Myers Squibb Company, Celgene Corporation, Novartis International AG, Eli Lilly and Company, Pfizer, Inc., UCB S.A., and AstraZeneca plc.
Comments
Post a Comment